Skip to content


Belrapzo, Bendeka, Treanda (bendamustine) is a small molecule pharmaceutical. Bendamustine was first approved as Belrapzo on 2008-03-20. It is used to treat lymphoid leukemia and non-hodgkin lymphoma in the USA. Treanda's patents are valid until 2033-03-15 (FDA).
Trade Name Belrapzo, Bendeka, Treanda
Common Name Bendamustine
Indication lymphoid leukemia, non-hodgkin lymphoma
Drug Class Antineoplastics (chloroethylamine derivatives)
Get full access now